Guliyev, M. et al. 2025. Evaluating the Prognostic Role of Pan-Immune-Inflammation Value in Patients with Advanced Non-Small Cell Lung Cancer Treated with Nivolumab. Cerrahpaşa Medical Journal. 49, 1 (Sep. 2025), 1–9. DOI:https://doi.org/10.5152/cjm.2025.25038.